183.12M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Cellectis S. A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants.

Similar securities

Based on sector and market capitalization

Report issue